Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Potential candidates for off-label use: Clinicians may consider GLP-1 therapy for women with PCOS who meet the following criteria: Overweight or obesity (particularly BMI 30 kg/m) with PCOS Insulin resistance or impaired glucose tolerance Inadequate response to lifestyle modification and other treatments No contraindications to GLP-1 therapy Not planning pregnancy in the immediate future Contraindications and precautions: GLP-1 receptor agonists are contraindicated in pregnancy and breastfeeding
Coverage varies by plan, however
Common Symptoms of Low Sex Drive Women experiencing low libido may notice: Persistent low or absent sex drive Reduced arousal or responsiveness during intimacy Difficulty maintaining interest or engagement Decreased sexual satisfaction Changes in desire related to stress, aging, or hormonal shifts Loss of confidence connected to intimacy Key Benefits of PT-141 When prescribed and monitored by a SynergenX provider, PT-141 may help: Increase sexual desire and interest Improve arousal and responsiveness Enhance overall sexual satisfaction Support confidence and connection in intimate relationships A Peptide for Sex Drive That Works Differently PT-141 is a peptide for sex that targets melanocortin receptors in the brain, which play a key role in sexual desire
Genetic and biological factors may play a role in treatment response, though this remains an area of ongoing research
Dentro del marco de uso exclusivamente para investigacin (RUO), la informacin de seguridad se aporta con fines cientficos y no constituye orientacin de uso clnico
